Koyfin Home > Directory > Health Care > Antares Pharma > Long-Term Debt / Capital

Antares Pharma Long-Term Debt / Capital Chart (ATRS)

Antares Pharma annual/quarterly Long-Term Debt / Capital from 2000 to 2018.
  • Antares Pharma Long-Term Debt / Capital for the quarter ending December 12, 2018 was $39m a -19.64% decrease of -8m year over year
  • Antares Pharma Long-Term Debt / Capital for the last 12 months ending December 12, 2018 was $39m a -19.64% decrease of -8m year over year
  • Antares Pharma Annual Long-Term Debt / Capital for 2018 was $39m a -8.63% decrease of -3m from 2017
  • Antares Pharma Annual Long-Term Debt / Capital for 2017 was $43m a 56.83% increase of 24m from 2016
  • Antares Pharma Annual Long-Term Debt / Capital for 2008 was $18m a -4.60% decrease of -1m from 2007
Other Ratios Metrics:
  • Antares Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $39m a -19.64% decrease of -8m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
  • Antares Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $64m a -36.97% decrease of -24m year over year
View Chart On Koyfin

Quarterly ATRS Long-Term Debt / Capital Data

12/2018$39m
09/2018$51m
06/2018$50m
03/2018$47m
12/2017$43m
09/2017$41m
06/2017$38m
09/2009$0m
06/2009$13m
03/2009$17m

Annual ATRS Long-Term Debt / Capital Data

2018$39m
2017$43m
2008$18m
2007$19m
2002$2m
2001$1m
2000$446m